Eton Pharmaceutcials Inc (ETON) Stock Price, Quote & News

Company Profile

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developi...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 847 787 7361

Website: www.etonpharma.com

Address:

21925 W. Field Parkway, Suite 235, Deer Park, United States

giavannasullivan77 Mar. 1 at 8:14 PM

$ETON biotech microcap watching for asymmetric breakout

0 · Reply

BioTechHealthX Mar. 1 at 3:33 PM

$ETON Eton Pharmaceuticals (NASDAQ: ETON) just secured U.S. FDA approval for DESMODA™, the first and only oral liquid desmopressin for central diabetes insipidus. With projected peak sales of $30–50 million and patent protection through 2044, is ETON stock entering a powerful new growth phase? https://biotechhealthx.com/biotech-news/is-it-still-safe-to-buy-eton-pharmaceuticals-eton-shares/

0 · Reply

BioTechHealthX Mar. 1 at 3:15 PM

$ADAP $ARVN $CING $CRVS $ETON A single FDA approval can double a small-cap biotech stock overnight. Discover 10 high-risk, high-reward FDA catalyst stocks with confirmed PDUFA dates this quarter that traders are watching for breakout moves, volatility spikes, and potential buyout speculation. https://biotechhealthx.com/biotech-news/top-10-small-cap-fda-catalyst-biotech-stocks/

0 · Reply

CharlieeMungerTWITS Feb. 27 at 12:52 PM

$ETON me tinks this will randomly shoot up 20%.

1 · Reply

Steve_TheBull_Rogers Feb. 26 at 7:58 PM

$ALDX Steve nailed $VNDA $RGNX and $ETON in 2 weeks too So yeah mention my wins pal VNDA 200%, RGNX 200% etc

2 · Reply

listenteme Feb. 26 at 4:53 PM

$ETON What happened to FDA date yesterday?

2 · Reply

alotobeer Feb. 26 at 3:45 PM

$ETON human logic defies all reason. At $17.36 no one wants it but when it hits $19 everyone will flood back in to make that $2 flip

0 · Reply

badgermobile Feb. 26 at 3:21 PM

$ETON whats Interesting Is stock price Is dropping with low volume but options pricing for August 15th are rising so people want this stock and see It going up after quarterly report.

1 · Reply

badgermobile Feb. 26 at 1:28 PM

$ETON It will rip back to 19 where It should have stayed except for the NVidia earnings scare. When we announce profitability and growth In 2 weeks this will take off. They start shipping the new drug March 9th adds 15-20 percent revenue to top line

0 · Reply

GTMStox Feb. 26 at 10:50 AM

$ETON hopefully this rips today

0 · Reply

US FDA approves Eton Pharma's hormonal disorder drug

Feb 25, 2026, 1:47 PM EST - 4 days ago

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

Feb 20, 2026, 6:50 AM EST - 9 days ago

Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th

Feb 2, 2026, 6:50 AM EST - 27 days ago

Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

Jan 23, 2026, 10:20 AM EST - 5 weeks ago

Eton Pharmaceuticals: An Undervalued Small Cap With High Growth

Nov 24, 2025, 4:30 PM EST - 3 months ago

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

Nov 12, 2025, 4:30 PM EST - 3 months ago

Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

Nov 6, 2025, 11:16 PM EST - 4 months ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 months ago

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

Oct 23, 2025, 4:30 PM EDT - 4 months ago

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Aug 20, 2025, 6:50 AM EDT - 6 months ago

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

Aug 8, 2025, 3:27 PM EDT - 7 months ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 5:02 AM EDT - 7 months ago

Eton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With Options

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 7:00 AM EDT - 7 months ago

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Jul 15, 2025, 9:33 AM EDT - 8 months ago

Eton Pharma Near Term Catalysts Vanish

Jul 8, 2025, 6:50 AM EDT - 8 months ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

Jun 27, 2025, 6:50 AM EDT - 8 months ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Jun 6, 2025, 5:26 PM EDT - 9 months ago

Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

May 29, 2025, 12:42 PM EDT - 9 months ago

FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue

May 28, 2025, 5:28 PM EDT - 9 months ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 21, 2025, 2:57 AM EDT - 10 months ago

Eton Pharmaceuticals Set To Dominate Orphan Drug Niche

May 14, 2025, 4:30 PM EDT - 10 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025, 10:40 PM EDT - 10 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 10 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 10 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Apr 28, 2025, 6:50 AM EDT - 10 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Apr 1, 2025, 7:00 AM EDT - 11 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Mar 25, 2025, 2:30 AM EDT - 1 year ago

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

Mar 18, 2025, 7:42 PM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript

Mar 18, 2025, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Mar 14, 2025, 6:50 AM EDT - 1 year ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Mar 4, 2025, 10:00 AM EST - 1 year ago

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®

Mar 4, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Mar 3, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Feb 7, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

Feb 6, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Jan 3, 2025, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

Dec 20, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Dec 3, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Nov 25, 2024, 6:50 AM EST - 1 year ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Nov 12, 2024, 8:01 PM EST - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 1 year ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:30 PM EST - 1 year ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 3, 2024, 6:30 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

Aug 22, 2024, 4:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 11, 2024, 8:15 AM EDT - 1 year ago

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 5:30 PM EDT - 1 year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Jul 15, 2024, 4:05 PM EDT - 1 year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

giavannasullivan77 Mar. 1 at 8:14 PM

$ETON biotech microcap watching for asymmetric breakout

0 · Reply

BioTechHealthX Mar. 1 at 3:33 PM

0 · Reply

BioTechHealthX Mar. 1 at 3:15 PM

0 · Reply

CharlieeMungerTWITS Feb. 27 at 12:52 PM

$ETON me tinks this will randomly shoot up 20%.

1 · Reply

Steve_TheBull_Rogers Feb. 26 at 7:58 PM

$ALDX Steve nailed $VNDA $RGNX and $ETON in 2 weeks too So yeah mention my wins pal VNDA 200%, RGNX 200% etc

2 · Reply

listenteme Feb. 26 at 4:53 PM

$ETON What happened to FDA date yesterday?

2 · Reply

alotobeer Feb. 26 at 3:45 PM

$ETON human logic defies all reason. At $17.36 no one wants it but when it hits $19 everyone will flood back in to make that $2 flip

0 · Reply

badgermobile Feb. 26 at 3:21 PM

$ETON whats Interesting Is stock price Is dropping with low volume but options pricing for August 15th are rising so people want this stock and see It going up after quarterly report.

1 · Reply

badgermobile Feb. 26 at 1:28 PM

0 · Reply

GTMStox Feb. 26 at 10:50 AM

$ETON hopefully this rips today

0 · Reply

WallStreetBuyDip Feb. 25 at 10:31 PM

Comparing trending tickers $ETON vs $MELI: ETON dropped to $17.65, a decline of 3.45%, on a trading volume of 1.1M shares, significantly above its average of 324.2K. MELI, meanwhile, fell by a sharper 8.05% to $1767.71 with 2.4M shares traded, also well above its usual volume of 462.4K. Both stocks experienced higher than normal trading activity and declines, but MELI's drop was both steeper and on a larger scale compared to its average volume.

0 · Reply

WallStreetBuyDip Feb. 25 at 10:16 PM

Comparing trending tickers $CAVA vs $ETON: CAVA has surged 26.36% to $85.67, trading heavily at 17.7M shares, significantly above its usual 4.2M. In contrast, ETON fell by 3.45% to $17.65, with its volume reaching 1.1M shares, about 3.4 times its average of 324.2K. Clearly, CAVA is showing a stronger positive reaction to its high trading volume compared to ETON, which is seeing less favorable price movement despite also experiencing higher than average trading activity.

0 · Reply

BullDonald Feb. 25 at 9:51 PM

$ETON Huge support at 17, almost 80% positions are in profit. some profit taking causing the volatility. there is no selling pressure so it should stabilize soon enough. kind of juicy though

1 · Reply

DumbMoneyIsFunny Feb. 25 at 9:45 PM

$ETON Who would have thought. !!! Typical profit taking. should stabilize.

0 · Reply

badgermobile Feb. 25 at 9:05 PM

$ETON I am in long term been since 4. They will abnounce another great quarter and profitability this baby will go back up

2 · Reply

alotobeer Feb. 25 at 8:56 PM

$ETON love a good double dip on a stock catalyst. Paid today when it broke $19, and am steady buying back in @$16-$17 levels. Friday can’t come soon enough for my second pay day

0 · Reply

BiotekInvestor Feb. 25 at 8:45 PM

$ETON When it started going back below 19.10, I felt like the run was over and I sold. Congrats to the others who did the same. For those that are still in it, I would hold it for at least 2 quarters.

2 · Reply

notreload_ai Feb. 25 at 8:45 PM

$ETON ... FDA approves DESMODA, the first ready-to-use liquid medicine for central diabetes insipidus. It helps stop extreme thirst & frequent peeing with easier, safer precise dosing for kids & adults. https://notreload.xyz/fda-approves-desmoda-oral-liquid-for-central-diabetes-insipidus/

0 · Reply

Steve_TheBull_Rogers Feb. 25 at 8:45 PM

$ETON NAILED IT

0 · Reply

papayte Feb. 25 at 8:35 PM

$ETON coil looks hot pop feels close

0 · Reply

stocksrus47 Feb. 25 at 8:35 PM

$ETON

0 · Reply

stocksrus47 Feb. 25 at 8:32 PM

$ETON don’t share any positive news with this stock with your friends or it’ll tank

0 · Reply

Market Cap	455.64M
Revenue (ttm)	39.01M
Net Income (ttm)	-3.82M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	16.74
Profit Margin	-9.79%
Debt to Equity Ratio	1.31

Volume	236,000
Avg Vol	248,988
Day's Range	N/A - N/A
Shares Out	26.82M
Stochastic %K	12%
Beta	1.19
Analysts	Strong Sell
Price Target	$30.00